September 11, 2023Open Access

The potential clinical value of plasma biomarkers in Alzheimer's disease

Kaj BlennowQingdao University

Douglas GalaskoUniversity of Minnesota RPRobert PerneczkyTexas Tech University

Key Points

Key points are not available for this paper at this time.

Abstract

There is a need for a minimally invasive Alzheimer's disease (AD) diagnostic tool. AD plasma biomarker tests exist at various stages of commercial development. Understanding the development stage of a test is important for its appropriate use. Plasma biomarker tests could function as a triage tool to streamline AD diagnosis. Further steps remain before AD plasma biomarkers can be used routinely.

AIに質問

Bookmark

View Full Paper

Cite This Study

Blennow et al. (Mon,) studied this question.

synapsesocial.com/papers/69dd3e7ffb7610310c101395 https://doi.org/https://doi.org/10.1002/alz.13455

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

AIに質問

Bookmark

View Full Paper